BlueWind Medical Ltd. announced that it has received $64 million in its series B funding round on May 9, 2022. The transaction was led by new investor ConvaTec Group Plc, which invested $30 million along with other investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
257.8 GBX | -6.46% | -8.78% | +5.57% |
03:16pm | Well, it isn't as bad as feared... | |
01:41pm | Peel Hunt Downgrades ConvaTec to Reduce from Add, Cuts PT | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.57% | 7.05B | |
-2.19% | 185B | |
-3.25% | 105B | |
-4.77% | 66.59B | |
+1.40% | 54.66B | |
+17.35% | 47.78B | |
+4.06% | 41.26B | |
+2.73% | 26.95B | |
+2.28% | 26.37B | |
+12.96% | 24.8B |
- Stock Market
- Equities
- CTEC Stock
- News ConvaTec Group Plc
- BlueWind Medical Ltd. announced that it has received $64 million in funding from ConvaTec Group Plc